AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays
The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different laboratories, and improve patient care.
United States Megan Craig Karene Weck Knowledgebase Pharm Pharmacogenetics Pgx Working Group Amp Pgx Working Group
Source: news-medical.net